The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
Open Access
- 19 December 2019
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 147 (4) , 1098-1106
Abstract
The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut‐off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut‐off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non‐participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut‐off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut‐off were detected in the subsequent round.Keywords
This publication has 20 references indexed in Scilit:
- Attendance and Yield Over Three Rounds of Population-Based Fecal Immunochemical Test ScreeningAmerican Journal of Gastroenterology, 2014
- European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition – Evaluation and interpretation of screening outcomesEndoscopy, 2012
- Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer ScreeningNew England Journal of Medicine, 2012
- Fecal Occult Blood Testing When Colonoscopy Capacity is LimitedJNCI: Journal of the National Cancer Institute, 2011
- Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohortThe Lancet Oncology, 2011
- Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopyGut, 2009
- Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levelsBritish Journal of Cancer, 2009
- Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?British Journal of Cancer, 2009
- Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk populationGut, 2008
- Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening PopulationGastroenterology, 2008